Evidence map›Paper›PMID 30356078›Full record

ArticleScientific reports2018

Angiogenic and Osteogenic Synergy of Human Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells Cocultured on a Nanomatrix.

Jun Chen, Lily Deng, Catherine Porter, Grant Alexander, Dhruv Patel, Jeremy Vines, Xixi Zhang, David Chasteen-Boyd, Hak-Joon Sung, Yi-Ping Li and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Jun ChenDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Lily DengDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Catherine PorterDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Grant AlexanderDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Dhruv PatelDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Jeremy VinesDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Xixi ZhangDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
David Chasteen-BoydDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Hak-Joon SungDepartment of Medical Engineering, Severance Biomedical Science Institute, College of Medicine, Yonsei University, Seoul, 120-752, Korea.
Yi-Ping LiDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Amjad JavedDepartment of Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Shawn GilbertDepartment of Orthopedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Kyounga CheonDepartment of Pediatric Dentistry, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States.
Ho-Wook JunDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States. hwjun@uab.edu.
University of Alabama at Birmingham · USYonsei University · KR

Funding

Prohealing multifunctional endothelium nanomatrix coated stentR01HL125391 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JUN, HO-WOOK · 2015 to 2019
$1.8M
NITRIC OXIDE RELEASING BIOMIMETRIC NANOMATRIX GELF OR ROOT REVITALIZATIONK08DE027401 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEON, KYOUNGA · 2017 to 2022
$798k
NHLBI NIH HHS R01 HL125391NIDCR NIH HHS K08 DE027401
6 · The paper itself

Abstract

To date, bone tissue regeneration strategies lack an approach that effectively provides an osteogenic and angiogenic environment conducive to bone growth. In the current study, we evaluated the osteogenic and angiogenic response of human mesenchymal stem cells (hMSCs) and green fluorescent protein-expressing human umbilical vein endothelial cells (GFP-HUVECs) cocultured on a self-assembled, peptide amphiphile nanomatrix functionalized with the cell adhesive ligand RGDS (PA-RGDS). Analysis of alkaline phosphatase activity, von Kossa staining, Alizarin Red quantification, and osteogenic gene expression, indicates a significant synergistic effect between the PA-RGDS nanomatrix and coculture that promoted hMSC osteogenesis. In addition, coculturing on PA-RGDS resulted in enhanced HUVEC network formation and upregulated vascular endothelial growth factor gene and protein expression. Though PA-RGDS and coculturing hMSCs with HUVECs were each previously reported to individually enhance hMSC osteogenesis, this study is the first to demonstrate a synergistic promotion of HUVEC angiogenesis and hMSC osteogenesis by integrating coculturing with the PA-RGDS nanomatrix. We believe that using the combination of hMSC/HUVEC coculture and PA-RGDS substrate is an efficient method for promoting osteogenesis and angiogenesis, which has immense potential as an efficacious, engineered platform for bone tissue regeneration.

Indexed as

Neovascularization, PhysiologicOsteogenesisBone RegenerationCells, CulturedCoculture TechniquesHumansHuman Umbilical Vein Endothelial CellsMesenchymal Stem CellsOligopeptidesRegenerative Medicinearginyl-glycyl-aspartyl-serineOligopeptides

Identifiers

PMID30356078
PMCPMC6200728
OpenAlexW2896435683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.